Skip to content

Drug interactions

Paclitaxel protein bound + Ranolazine

Severity: Minor

Paclitaxel protein bound and Ranolazine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine inhibits P-glycoprotein and may modestly raise exposure to P-gp substrates. The clinical effect on nab-paclitaxel is not well characterized, but higher exposure could increase myelosuppression and neuropathy.

What this interaction means in plain words

Paclitaxel protein bound and Ranolazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux by ranolazine, which may reduce paclitaxel efflux.

What to do

No routine dose change is needed. Monitor blood counts and signs of peripheral neuropathy as part of standard chemotherapy care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Paclitaxel protein bound and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Paclitaxel protein bound with Ranolazine?

MediHelp rates the interaction as minor. Paclitaxel protein bound and Ranolazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ranolazine inhibits P-glycoprotein and may modestly raise exposure to P-gp substrates. The clinical effect on nab-paclitaxel is not well characterized, but higher exposure could increase myelosuppression and neuropathy.

How serious is the interaction between Paclitaxel protein bound and Ranolazine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor blood counts and signs of peripheral neuropathy as part of standard chemotherapy care.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in